Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development

The Special Issue "Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development" addresses the latest efforts towards discovering new antibiotics. The articles in this Special Issue cover various topics concerning antibacterial drugs. They provide valuable insights into the c...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
বিন্যাস: Online
ভাষা:ইংরেজি
প্রকাশিত: MDPI - Multidisciplinary Digital Publishing Institute 2023
বিষয়গুলি:
অনলাইন ব্যবহার করুন:ONIX_20230511_9783036572017_13
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
_version_ 1869519601845403648
collection Directory of Open Access Books
description The Special Issue "Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development" addresses the latest efforts towards discovering new antibiotics. The articles in this Special Issue cover various topics concerning antibacterial drugs. They provide valuable insights into the challenges and opportunities facing the field of antibiotic research and offer innovative solutions to tackle the growing problem of antibiotic resistance. The content of this Special Issue addresses antibacterial quinolones of the latest generation, new tetracyclines (such as glycylcyclines, aminomethylcyclines, and fluorocyclines), metal complexes (Ru (II/III) frameworks and Co(III) complexes with diamine chelate ligands), various nanoparticles (gold, silver and titanium dioxide nanoparticles), bioactive compounds produced by Mixobacterials species, anti-mycobacterial compounds acting as phosphopantetheinyl transferase inhibitors. The research in this Special Issue will contribute to pharmaceutics and ultimately contribute to developing new and effective antibiotics. We are grateful to the authors for their contributions and hope this Special Issue will stimulate further research and discussion on antibiotics. We also thank the reviewers for their time and expertise, and the editorial team for supporting this Special Issue. Finally, we hope this Special Issue will serve as a valuable resource for researchers, clinicians, and policymakers working towards a future where antibiotics remain vital in our fight against infectious diseases.
format Online
id doab-20.500.12854ir-99996
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-999962024-09-16T10:58:38Z Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development Rusu, Aura Uivarosi, Valentina Tanase, Corneliu ruthenium antimicrobial antibacterial antiviral antiparasitic COVID-19 Co(III) coordination complexes antibacterial activity microbroth dilution method minimum inhibitory concentration minimum bactericidal concentration synergy assay serial passages assay DNA interactions PPTase NRPS indigoidine PptT antibiotic screening antibiotics bioactive compounds medication Myxobacteria human diseases fluoroquinolones quinolones structure-activity relationship DNA gyrase topoisomerase IV antibiotic resistance antimicrobial resistance Lepidium sativum L. silver nanoparticles biomaterials antimicrobial activity synergism green synthesis surgical site infection wound dressing oral bacteria Rothia mucilaginosa TiO2NPs biofilm inhibition Arthrobacter bangladeshi MAHUQ-56T AgNPs S. typhimurium Y. enterocolitica antimicrobial peptides synergistic effect CRAB antibacterial resistance ceftriaxone gold nanoparticles MIC50 tetracyclines mechanism resistance fluorocycline aminomethylcycline glycylcycline thema EDItEUR::M Medicine and Nursing thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries The Special Issue "Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development" addresses the latest efforts towards discovering new antibiotics. The articles in this Special Issue cover various topics concerning antibacterial drugs. They provide valuable insights into the challenges and opportunities facing the field of antibiotic research and offer innovative solutions to tackle the growing problem of antibiotic resistance. The content of this Special Issue addresses antibacterial quinolones of the latest generation, new tetracyclines (such as glycylcyclines, aminomethylcyclines, and fluorocyclines), metal complexes (Ru (II/III) frameworks and Co(III) complexes with diamine chelate ligands), various nanoparticles (gold, silver and titanium dioxide nanoparticles), bioactive compounds produced by Mixobacterials species, anti-mycobacterial compounds acting as phosphopantetheinyl transferase inhibitors. The research in this Special Issue will contribute to pharmaceutics and ultimately contribute to developing new and effective antibiotics. We are grateful to the authors for their contributions and hope this Special Issue will stimulate further research and discussion on antibiotics. We also thank the reviewers for their time and expertise, and the editorial team for supporting this Special Issue. Finally, we hope this Special Issue will serve as a valuable resource for researchers, clinicians, and policymakers working towards a future where antibiotics remain vital in our fight against infectious diseases. 2023-05-11T17:15:53Z 2023-05-11T17:15:53Z 2023 book ONIX_20230511_9783036572017_13 9783036572017 9783036572000 https://directory.doabooks.org/handle/20.500.12854/99996 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7089 https://mdpi.com/books/pdfview/book/7089 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7200-0 10.3390/books978-3-0365-7200-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036572017 9783036572000 296 Basel open access
spellingShingle ruthenium
antimicrobial
antibacterial
antiviral
antiparasitic
COVID-19
Co(III) coordination complexes
antibacterial activity
microbroth dilution method
minimum inhibitory concentration
minimum bactericidal concentration
synergy assay
serial passages assay
DNA interactions
PPTase
NRPS
indigoidine
PptT
antibiotic screening
antibiotics
bioactive compounds
medication
Myxobacteria
human diseases
fluoroquinolones
quinolones
structure-activity relationship
DNA gyrase
topoisomerase IV
antibiotic resistance
antimicrobial resistance
Lepidium sativum L.
silver nanoparticles
biomaterials
antimicrobial activity
synergism
green synthesis
surgical site infection
wound dressing
oral bacteria
Rothia mucilaginosa
TiO2NPs
biofilm inhibition
Arthrobacter bangladeshi MAHUQ-56T
AgNPs
S. typhimurium
Y. enterocolitica
antimicrobial peptides
synergistic effect
CRAB
antibacterial resistance
ceftriaxone
gold nanoparticles
MIC50
tetracyclines
mechanism
resistance
fluorocycline
aminomethylcycline
glycylcycline
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development
title Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development
title_full Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development
title_fullStr Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development
title_full_unstemmed Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development
title_short Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development
title_sort focus on antibiotics new challenges and steps forward in discovery and development
topic ruthenium
antimicrobial
antibacterial
antiviral
antiparasitic
COVID-19
Co(III) coordination complexes
antibacterial activity
microbroth dilution method
minimum inhibitory concentration
minimum bactericidal concentration
synergy assay
serial passages assay
DNA interactions
PPTase
NRPS
indigoidine
PptT
antibiotic screening
antibiotics
bioactive compounds
medication
Myxobacteria
human diseases
fluoroquinolones
quinolones
structure-activity relationship
DNA gyrase
topoisomerase IV
antibiotic resistance
antimicrobial resistance
Lepidium sativum L.
silver nanoparticles
biomaterials
antimicrobial activity
synergism
green synthesis
surgical site infection
wound dressing
oral bacteria
Rothia mucilaginosa
TiO2NPs
biofilm inhibition
Arthrobacter bangladeshi MAHUQ-56T
AgNPs
S. typhimurium
Y. enterocolitica
antimicrobial peptides
synergistic effect
CRAB
antibacterial resistance
ceftriaxone
gold nanoparticles
MIC50
tetracyclines
mechanism
resistance
fluorocycline
aminomethylcycline
glycylcycline
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
topic_facet ruthenium
antimicrobial
antibacterial
antiviral
antiparasitic
COVID-19
Co(III) coordination complexes
antibacterial activity
microbroth dilution method
minimum inhibitory concentration
minimum bactericidal concentration
synergy assay
serial passages assay
DNA interactions
PPTase
NRPS
indigoidine
PptT
antibiotic screening
antibiotics
bioactive compounds
medication
Myxobacteria
human diseases
fluoroquinolones
quinolones
structure-activity relationship
DNA gyrase
topoisomerase IV
antibiotic resistance
antimicrobial resistance
Lepidium sativum L.
silver nanoparticles
biomaterials
antimicrobial activity
synergism
green synthesis
surgical site infection
wound dressing
oral bacteria
Rothia mucilaginosa
TiO2NPs
biofilm inhibition
Arthrobacter bangladeshi MAHUQ-56T
AgNPs
S. typhimurium
Y. enterocolitica
antimicrobial peptides
synergistic effect
CRAB
antibacterial resistance
ceftriaxone
gold nanoparticles
MIC50
tetracyclines
mechanism
resistance
fluorocycline
aminomethylcycline
glycylcycline
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
url ONIX_20230511_9783036572017_13